相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolism and cancer: the future is now
Christian Frezza
BRITISH JOURNAL OF CANCER (2020)
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
Ramesh Pothuraju et al.
MOLECULAR CANCER (2020)
MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy
Shailendra K. Gautam et al.
SEMINARS IN IMMUNOLOGY (2020)
Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer
Ramesh Pothuraju et al.
CANCERS (2020)
Unraveling mucin domains in cancer and metastasis: when protectors become predators
Koelina Ganguly et al.
CANCER AND METASTASIS REVIEWS (2020)
The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy
Mei Guo et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer
Mei Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis
Maxime Liberelle et al.
SCIENTIFIC REPORTS (2019)
Cancer-associated mucins: role in immune modulation and metastasis
Rakesh Bhatia et al.
CANCER AND METASTASIS REVIEWS (2019)
Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
Xin GongSun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view
Shiv Ram Krishn et al.
CARCINOGENESIS (2018)
Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets
Suresh Sulekha Dhanisha et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
MUC16 as a novel target for cancer therapy
Abhijit Aithal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line
Priyanka Grover et al.
Oncotarget (2018)
MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
Sonam Kumari et al.
ONCOGENESIS (2018)
Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate
Govind Panchamoorthy et al.
JCI INSIGHT (2018)
High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma
Zhiying Xu et al.
ONCOTARGET (2017)
MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance
Yonghua Sheng et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Jasmim Leal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer
Jos P. M. van Putten et al.
JOURNAL OF INNATE IMMUNITY (2017)
Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells
Jun Sang Bae et al.
ONCOLOGY REPORTS (2017)
MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner
Wei Jin et al.
CELL DEATH & DISEASE (2017)
MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling
I. Lakshmanan et al.
ONCOGENE (2016)
Mucin 1-mediated chemo-resistance in lung cancer cells
S. Y. Ham et al.
ONCOGENESIS (2016)
Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
Hui Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2015)
MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism
Surendra K. Shukla et al.
ONCOTARGET (2015)
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells
Srustidhar Das et al.
ONCOTARGET (2015)
Mucins and tumor resistance to chemotherapeutic drugs
Nicolas Jonckheere et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
MUC1: A novel metabolic master regulator
Kamiya Mehla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
See-Hyoung Park et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition
H. Rajabi et al.
ONCOGENE (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Lipid metabolism in cancer Preface
Daniel K. Nomura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models
Sandip Pravin Patel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Mucus as a barrier to lipophilic drugs
Hakon H. Sigurdsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
MUC1-C Oncoprotein Activates ERK→C/EBPβ Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells
Maroof Alam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
Jennifer M. Curry et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Mucins in pancreatic cancer and its microenvironment
Sukhwinder Kaur et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
N. Skrypek et al.
ONCOGENE (2013)
SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance
Soyoung Lim et al.
PLOS ONE (2013)
Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer
Suguru Yamada et al.
SURGERY (2013)
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
S. Nath et al.
ONCOGENESIS (2013)
MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1
Satyanarayana Rachagani et al.
CARCINOGENESIS (2012)
Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells
Deepak Raina et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Lysophosphatidic Acid Activates Lipogenic Pathways and de Novo Lipid Synthesis in Ovarian Cancer Cells
Abir Mukherjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Embryonic Stem Cell Markers
Wenxiu Zhao et al.
MOLECULES (2012)
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
Nina V. Chaika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma A Multicenter Comparative Study
Mathieu Messager et al.
ANNALS OF SURGERY (2011)
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
M. Comamala et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
L. D. Roy et al.
ONCOGENE (2011)
Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
Dhanya Haridas et al.
PLOS ONE (2011)
MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
Michio Kosugi et al.
PLOS ONE (2011)
MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
Moorthy P. Ponnusamy et al.
JOURNAL OF OVARIAN RESEARCH (2011)
O-Fucose Modulates Notch-Controlled Blood Lineage Commitment
Quanjian Yan et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
Murielle Mimeault et al.
CANCER LETTERS (2010)
Core Fucosylation Is Required for Midline Patterning During Zebrafish Development
Anandita Seth et al.
DEVELOPMENTAL DYNAMICS (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
S. Bafna et al.
ONCOGENE (2010)
MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells
M. P. Ponnusamy et al.
ONCOGENE (2010)
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
Wolfgang Hagmann et al.
NEOPLASIA (2010)
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
T. Mashima et al.
BRITISH JOURNAL OF CANCER (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours
Ashish V. Kalra et al.
EUROPEAN JOURNAL OF CANCER (2009)
ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1
Galit Horn et al.
EXPERIMENTAL CELL RESEARCH (2009)
CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
Marianne Boivin et al.
GYNECOLOGIC ONCOLOGY (2009)
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment
Sean P. Pitroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure, evolution, anal biology of the MUC4 mucin
Pallavi Chaturvedi et al.
FASEB JOURNAL (2008)
Persistence of side population cells with high drug efflux capacity in pancreatic cancer
Jing Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62
Yumei Leng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2
Victoria P. Ramsauer et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
S14 protein in breast cancer cells: Direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth
PM Martel et al.
EXPERIMENTAL CELL RESEARCH (2006)
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Y. Liu
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus
LR Shaw et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
K Yoshida et al.
CANCER SCIENCE (2004)
The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts
D Raina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
分享论文
